Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

A new type of nerve cell involved in itch perception was discovered.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Id2 gene helps keep hair follicle stem cells inactive.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

miR‑339‑5p can slow down hair follicle stem cell differentiation by targeting DLX5.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Low IRES/Cap translation is linked to higher stem cell potential.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

LEF-1 boosts cell growth in goat hair follicles, aiding cashmere production.

miR-22 helps skin cancer grow and spread by activating specific cell signals.